Gemtesa 75 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F6Y5L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,246
Award facts
- Contract value 100% obligated
- $11,245.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,245.60 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) with a completion date of February 2, 2026. This is a firm fixed-price, non-set-aside contract awarded competitively on January 30, 2026, with performance to take place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across the Department of Defense and other government healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The contract demonstrates AmerisourceBergen's ongoing role in fulfilling essential pharmaceutical needs for military treatment facilities and other federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F6Y5L?
SPE2DR26F6Y5L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F6Y5L worth?
The government has obligated $11,246 on SPE2DR26F6Y5L.
Is contract SPE2DR26F6Y5L an order under another contract?
Yes. SPE2DR26F6Y5L is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6Y5L competed?
The extent of competition for SPE2DR26F6Y5L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award